CISH and neoplasm: In mouse models, we have shown that the deletion of SOCS1 or NR4a in T cells regresses cancers due to strong tumor immunity.96,117) We will continue our research in pursuit of the application of SOCS and NR4a to the treatment of autoimmune diseases and cancers in humans.